Edison Investment Research Limited · ISIN: GB0000385517 · EQS - Company News

Edison issues report on The Biotech Growth Trust (BIOG)

  London, UK, 18 March 2025   Edison issues report on The Biotech Growth Trust (BIOG) Edison issues report on The Biotech Growth Trust (LSE: BIOG) The Biotech Growth Trust’s (BIOG’s) highly experienced managers, Geoff Hsu and Josh Golomb, are able to draw on the considerable resources of global healthcare specialist OrbiMed. BIOG’s performance has been particularly challenging as the managers favour emerging (less mature) biotech companies, which have fared particularly poorly versus the S...

Corporate Insights - Short Sales, Director's Dealings, Sentiment Indicators - THE info hub for the informed investor

Smart tools for smart investors can be found in our Tools section

Corporate News Edison Investment Research Limited

In this overview you can view company news in the chronological order of publication. The source information comes from EQS News, the leading European news distributor. The most recent news item is listed first.
18 March 2025 04:47PM
Edison issues report on The Biotech Growth Trust (BIOG)
  London, UK, 18 March 2025   Edison issues report on The Biotech Growth Trust (BIOG) Edison issues report on The Biotech Growth Trust (LSE: BIOG) The Biotech Growth Trust’s (BIOG’s) highly experienced managers, Geoff Hsu and Josh Golomb, are able to draw on the considerable resources of global healthcare specialist OrbiMed. BIOG’s performanc...
Edison Investment Research Limited
20 August 2024 01:07PM
Edison issues report on The Biotech Growth Trust (BIOG)
  London, UK, 20 August 2024   Edison issues report on The Biotech Growth Trust (BIOG) Edison issues report on The Biotech Growth Trust (LSE: BIOG) Click here to read the full report. All reports published by Edison are available to download free of charge from its website www.edisongroup.com Edison is authorised and regulated by the Financi...
Edison Investment Research Limited
20 March 2024 10:09AM
Onwards and upwards for performance recovery
  London, UK, 20 March 2024   Edison issues update on The Biotech Growth Trust (BIOG): Onwards and upwards for performance recovery The Biotech Growth Trust’s (BIOG’s) two co-managers, Geoff Hsu and Josh Golomb, at global healthcare specialist OrbiMed, believe that now could be an opportune time to consider the biotech sector as it is recoverin...
Edison Investment Research Limited
More Edison Investment Research Limited related information
Type Total Last Made by Go to
Corporate Research 0 - - Corporate Research
Directors Dealings 0 - - DD
Short Seller (DE) 0 - - SSR (DE)
Short Seller (UK) 1 28th March 2025 Citadel Securities (Europe) Limited SSR (UK)
Disclaimer:

The combination of information with graphic elements makes an important contribution to visual orientation and navigation through complex factual topics. Essential content features can be perceived, grasped and contextually processed much faster. 
The figurative marks, logos and other graphic and textual elements used on this website are for illustrative purposes only. All rights to the aforementioned elements are held by their respective owners. They are used without the intention of copyright infringement or intellectual property infringement.

If you believe that copyrights or intellectual property have been infringed by the choice of illustration, please contact us immediately to clarify the issue.

v.07062023 EN